Dr. Abubaker Almadani completed his undergraduate certificate in 1997 from the University of Gothenburg, Sweden. In Gothernburg University, he was involved in teaching and contributed in research study with Dr. Anders Hamberger in neuroprotective agents in acute stroke. Then, he completed his Canadian Royal College in Neurology (FRCPC) in 2009.<br><br>

Dr. Madani had his residency at the University of Toronto which is ranked number 1 in Canada by Royal College of Canada, and ranked number 4 in the whole North America by American Academy of Neurology. He was personally involved in regional stroke program and he was involved in at least 500 stroke cases and 80 TPA cases. In his residency he also did one whole elective year which involves EEG, research, pathology and nerve conduction studies. By finishing the residency, he was able to manage neurological cases as general neurological cases as general neurologist in 2007. He has his fellowship in neuromuscular subspecialty from 2007 to 2009.

Dr. Ahmed Mahmoud Elsayed Hassan is a specialist neurologist. He graduated in 2007, obtained a
Master’s in Neurology from Mansoura University in 2013, and earned the MRCP (UK) Specialty
Certificate in Neurology in 2019. He worked in Kuwait until 2022 and is now practicing at Tawam
Hospital and STMC in the UAE. He is accredited as an AANEM Clinical Neurophysiology Additional
Physician, has multiple publications, and is a co-investigator in several clinical trials. His clinical
interests include neuromuscular disorders, EMG, neurophysiology, neuroimmunology, and multiple
sclerosis.

Dr. Ahmed Samir holds a Master’s degree in Neurology from Egypt (2014) and obtained a Stroke and Vascular Neurology Fellowship from the APPNA Academy in October 2024.

Dr. Samir has more than 14 years of clinical experience in neurology. He spent approximately eight years practicing at Al Jahra Hospital in Kuwait before joining Tawam Hospital in April 2023. He currently serves as a Neurology Specialist at both STMC and Tawam Hospital.

In addition to his clinical work, Dr. Samir is actively involved in medical research and has multiple publications in the fields of Multiple Sclerosis, Migraine, and Stroke.

Dr. Quateen developed his expertise in interventional Neuroradiology throughout his career, which spans more than 16 years. He has taken a special interest in diagnostic and interventional neuroradiology. Dr. Quateen is well-trained in the subspecialties of interventional neuroradiology and interventional vascular radiology. He specialises in the diagnosis and treatment of neurological conditions and the use of clinical imaging to conduct vascular procedures. Dr. Quateen is also a keen educator and has published several research papers. Dr. Quateen received his MBBCh degree from Tripoli University and is Canadian Board Certified Diagnostic Radiology. In addition, Dr. Quateen is a fellow of the prestigious Royal College of Physicians and Surgeons of Canada. He also holds three fellowships in interventional vascular radiology, interventional neuroradiology, and neuroradiology. Dr. Quateen served as an Assistant Professor at Dalhousie University and the University of Ottawa in Canada before joining our ranks at SSMC, Abu Dhabi in UAE.

Dr. Ali Hassan is a Consultant Neurologist and Chief of the Neurology Division at STMC and Tawam Hospitals in Al Ain, UAE. He completed his MD in neurology from Al Azhar University, with specialized training in epilepsy and EEG from Case Western Reserve University, USA. He led the development of accredited stroke centers and founded key neurology conferences in the region. With over 40 publications, he is active in international research and guideline development. Dr. Hassan also trains neurologists in botox therapy and has received awards for teaching and quality leadership.

Dr. Anu Jacob, MD, DM, FRCP, is a Staff Physician in the Neurological Institute and Director of Multiple Sclerosis and Autoimmune Neurology at Cleveland Clinic Abu Dhabi.

Prior to joining Cleveland Clinic Abu Dhabi, Dr. Jacob was a consultant neurologist at the Walton Center for neurology and neurosurgery in Liverpool, United Kingdom. 

Dr. Jacob received his medical degree and internal medicine residency from Jawaharlal Institute of Postgraduate Medical Education and Research, India and neurological certification (DM) training at Sri Chitra Tirunal Institute, Thiruvananthapuram, India. He received his Membership of the Royal College of Physicians and Neurology Board certification in the UK and completed his fellowship in Multiple Sclerosis and Neuromyelitis Optica at Mayo Clinic, Rochester, Minnesota.  

Dr. Jacob served as the National Director for the United Kingdom NHS specialist service for Neuromyelitis optica and he was also the Director for multiple sclerosis services for North Wales, caring for more than 1000 patients affected by the condition. Whilst in the UK, Dr Jacob set up the National NMO service (the first ever comprehensive NMO service in the world) and was awarded the  Royal College of physicians Excellence in patient care award for his work that changed the lives of patients with NMO in UK. 

Dr. Jacob is passionate about education and research and published 3 doctoral theses during his training. Putting his knowledge and skills into practice he has published more than 100 peer reviewed research articles and several book chapters and he was the Chief /Principal or co-investigator for several clinical trials on MS or NMO and has received several research grants. He enjoys teaching at all levels and regularly lectures medical students and nurses, is an examiner for PHD degrees both in UK and abroad and has given more than 100 lectures across the world including at the American Academy of Neurology, European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) and British Neurological Association.

Dr. Chaouki Khoury, MD, brings over a decade of experience in neurology and headache medicine to PANDA Neurology & Atlanta Headache Specialists serving patients in and around metro Atlanta.
Dr. Khoury began his professional education at The American University of Beirut in Beirut, Lebanon. He graduated summa cum laude, then completed a combined masters in neuroscience and earned his Doctor of Medicine degree.
Following graduation, Dr. Khoury relocated to the United States and completed a neurology residency at The University of Oklahoma Health Sciences Center in Oklahoma City. After finishing his residency, Dr. Khoury moved to Texas and participated in a fellowship in child neurology at Texas Children’s Hospital/Baylor College of Medicine in Houston.
After completing his fellowship, Dr. Khoury returned to Oklahoma and was the residency program director.  He then moved to Texas and served as the medical students’ neurology clerkship director, headache fellowship director and director of the comprehensive headache institute at Baylor, before joining Texas Neurology and serving as the associate director of their Comprehensive Headache Institute in Dallas. There, he focused on clinical research and advanced therapies for the treatment of patients with acute and chronic headaches.  Dr. Khoury is currently an adjunct clinical professor at Morehouse School of Medicine.

Dr. Khoury is board certified and provides neurological care for adults and children alike. He welcomes anyone seeking comprehensive neurological care to PANDA Neurology & Atlanta Headache Specialists.

Dr. Darakhshan Naheed is a specialist neurologist with expertise in the management of a broad spectrum of neurological disorders. She earned her DM in Neurology from the Postgraduate Institute of Medical Education and Research (PGIMER), India, and completed a clinical fellowship in Parkinson’s disease and movement disorders at the National Neuroscience Institute, Singapore. Having practiced in India and the UAE, she combines strong clinical acumen with academic excellence. Her research has been published in peer-reviewed journals, and she has showcased her work at the International Congress of Parkinson’s Disease and Movement Disorders in the USA.

Dr. Farida Almarzooqi is an Assistant Professor and Consultant in Clinical Immunology and Allergy at the College of Medicine & Health Sciences, United Arab Emirates University. She completed her Internal Medicine residency at the University of British Columbia and advanced fellowship training in Clinical Immunology and Allergy at McGill University, with additional elective experience at the Children’s Hospital of Philadelphia. Her clinical and research work focuses on inborn errors of immunity, and systemic immune dysregulation with publications on genetic variants in immune disorders. She leads national projects, including creating the genetic database for allergic and immunologic diseases, and is committed to advancing precision medicine.

Ms. Fatma Alsawwafi is a dedicated stroke navigator specializing in coordinating and optimizing the care pathway for acute stroke patients. With strong background in nursing and passion for improving patients’ outcomes,  I am playing vital role in early recognition and multidisciplinary collaboration in stroke unit. I am leading stroke codes, support BEFAST documentation and early recognition of stroke or deterioration in patient condition. Also, she actively involved in community awareness events that aim to increase the awareness on recognition of stroke among UAE community.

Dr. Florian Roser, MD, is Chief Medical Officer at Cleveland Clinic Abu Dhabi, part of the M42 group. In his role as Chief Medical Officer, he oversees the functions of Allied Health, Pharmacy and Clinical Risk, strengthening clinical operations and solidifying the hospital’s commitment to being the best place to receive care. Dr. Roser is also Institute Chief of Cleveland Clinic Abu Dhabi's Neurological Institute.

Dr. Roser, a board-certified neurosurgeon (Germany, UK, and UAE), joined Cleveland Clinic Abu Dhabi in 2014 and has led the Neurological Institute as Chair since 2019. His expertise and strategic leadership have been instrumental in advancing neurological care within our organisation and in the UAE.

Prior to joining Cleveland Clinic Abu Dhabi, Dr. Roser was the Vice-Chairman of the Department of Neurosurgery at the University of Tübingen, Germany.

Gina Lee is a Certified MS nurse specialist at Cleveland Clinic Abu Dhabi with the Neurology Clinic since 2020. She holds a Bachelor's degree in Nursing from the Metropolitan University in Toronto, Ontario, Canada. She is Certified Multiple Sclerosis Nurse by the U.S. Multiple Sclerosis Nurses International Certification Board (MSNICB) in 2022. She obtained as well her UK MS Certification (MS Nurse Pro) in 2020. 

Janeth Eroela Billones, 37, is a dedicated healthcare professional whose career reflects passion, commitment, and continuous growth in the field of nursing. She began her medical journey as a staff nurse at Tawam Hospital, where she served for eight years with exemplary compassion and professionalism. During her years of service, she developed a strong foundation in patient care, clinical assessment, and multidisciplinary collaboration—skills that would later elevate her into leadership.

After nearly a decade of devoted service as a staff nurse, Janeth advanced in her career and now serves as the Charge Nurse of the Neurology and Neurosurgery Outpatient Department. In this role, she oversees daily clinical operations, coordinates patient flow, and supports her team in delivering safe, timely, and patient-centered care. Her leadership is recognized for being approachable, organized, and solution-oriented. Janeth is known for her ability to guide and mentor nurses, ensuring quality standards are consistently met while fostering a collaborative and harmonious workplace.

Dr. Al-Hashel is an adult neurologist and Headache specialist. He is a graduate of the college of medicine, Kuwait University, Kuwait.
Dr. Al-Hashel completed his neurology residency as well as his fellowship in headache and Botulinum toxin injection at McGill University, Canada.
Dr. Al-Hashel is board certified from the Royal college of Physicians and Surgeon of Canada (FRCPC) and had also American fellowship in Headache Medicine (FAHS) and Canadian fellowship in Headache Medicine from McGill University. 
He is a Consultant Neurologist and Professor of Neurology at Kuwait University, faculty of medicine in Kuwait. He established the headache and the Botulinum toxin clinic in Ibn Sina and Mubarak Al-Kabeer Hospitals in Kuwait. 
Dr. Al-Hashel also the Chair of the faculty of Neurology in Kuwait and the President of Kuwait Neurological Society and the Vice President of Pan Arab Union of Neuroscience (PAUNS). 
Dr. Al-Hashel has more than 100  publications in the field of Neurology and author a chapter in chronic fatigue syndrome (CFS) in International neurology book, Second edition.
Dr. Al-Hashel was awarded as best researcher in Kuwait University in 2015.
Dr. Al-Hashel was awarded by H.H the Amer of Kuwait Sheikh Sabah for scientific achievements in Medical Sciences and Allied Health Sciences 2019.

Khuloud Saif Alkaabi is a dedicated Nurse Manager at STMC, Al Ain, UAE, with over ten years of professional experience in critical and medical care units. She holds a Bachelor of Science in Nursing from Fatima College of Health Sciences and a Master’s in Business Administration specializing in Human Resources from Abu Dhabi University. Throughout her career, Khuloud has led quality improvement initiatives, enhanced patient-safety standards, and mentored multidisciplinary teams. Known for her leadership, compassion, and commitment to excellence, she continues to advance clinical performance and patient outcomes within the CCU, SCU, and long-term ventilator care units She’s awarded with Daisy Award in leadership.

Dr. Laila Abdel Wareth, is a physician executive. She is currently the Chief Executive Officer, 
Diagnostics, Global patient Care Platform, M42, Chief Executive Officer at the National Reference 
Laboratory, previous Chair of Pathology & Laboratory Medicine Institute at the Cleveland Clinic Abu Dhabi, Adjunct Clinical Professor, Department of Pathology, College of Medicine & Health Sciences at Khalifa University. Dr Laila also holds a position also as the President of The Emirates Clinical 
Chemistry Society under Emirates Medical Association in the UAE. 
Prior to joining the National Reference Laboratory, Dr. Abdel Wareth served as Chief Medical Officer of SEHA Pathology and Laboratory Medicine Services and Chair of Pathology and Laboratory 
Medicine Institute at Sheikh Khalifa Medical City.
She brings more than twenty-eight years of experience in healthcare, also including roles at British Columbia Children’s & Women’s Hospital in Vancouver, Canada and Mafraq Hospital, Abu Dhabi,UAE.
Dr. Abdel Wareth earned her medical degree from Ain Shams University Cairo, Egypt and completed 
her postgraduate training at the University of British Columbia, Canada, in the specialty of Medical Biochemistry and Clinical Pathology.
She obtained Canadian and American Boards accreditation in Medical Biochemistry and Clinical 
Pathology and is a fellow of the Royal College of Physicians and Surgeons in Canada, the College of American Pathologists. In addition to her clinical degrees, Dr. Abdel Wareth has an Executive 
Master’s Degree in Healthcare Administration from Zayed University, UAE.
She is an active member in various scientific societies and has several publications to her credit in the field of Laboratory Medicine.

Dr. Maria Junaidi is a neurologist practicing in Rashid Hospital, Dubai for the past eight years.
She is a graduate of the Aga Khan University in Karachi, Pakistan and completed her post graduate training from the same institute.
She holds a fellowship in vascular neurology and is one of the founding members for MENA stroke organization.
She is also an avid researcher and has a number of publications in international peer reviewed journals.

Dr. Mohammed Alhatou has a special interest in headache, neuro-immunology and neuromuscular diseases. He chaired the Department of Neurology at the Regional Medical Center of Orangeburg and Calhoun Counties from 2002 to 2015 and recently joined Hamad Medical Corporation where he is a Senior Consultant, Director of Neuromuscular Division at HMC and Head of Neurology at Alkhor Hospital.

Dr. Alhatou is American Board-Certified in Neurology, Clinical Neurophysiology, Electromyography, Neuromuscular Disorders, Neuroimaging and Sleep Medicine. He completed his Residency in Neurology at the University of Virginia and his Fellowship in Neuromuscular Disease and Electromyography at Emory University.

He is a primary investigator in multiple drug studies in neuropathy, dementia, stroke and epilepsy. He is the Chair of Qatar Board of Neurology and Qatar representative to Arab Board of Neurology.  

British trained consultant Neurosurgeon with highly specialised fellowships in open and endoscopic skull base surgery in the U.K. , France and Canada as well as Neuroncology (Canada). Dr Asha is currently the Chief of the Neurosurgery Department at Tawam Hospital (National Oncology Tertiary Centre in Abu Dhabi). Dr Asha is a pioneer in complex brain tumors surgery in UAE for adults and pediatrics. He has keen interest in open vascular surgery and functional Neurosurgery as well. Dr Asha is very motivated educator. He holds masters degree in evidence based medicine, Cardiff University and A degree in Global Health Education, University of Toronto. In addition to his clinical roles, he holds a position as adjunct professor at the University of UAE.

Dr. Noho Solieman is currently working as a Consultant Neurologist and Epileptologist at Tawam Hospital in Al Ain, United Arab Emirates. She delivered numerous speeches at conferences for neurology. She holds Clinical Neurophysiology Epilepsy Tract Qualification from the American Board of Neurology and ECFMG Certification.

Dr. Noha is a Member of the American Clinical Neurophysiology Society, the American Epilepsy Society, and the American Academy of Neurology.

She received recognition from the Department of Neurology at Howard University Hospital for her outstanding work as a postgraduate trainee and chief resident in neurology. She also received a scholarship for the 65th annual meeting of the American Academy of Neurology and was recognized as the winner of the best oral presentation at the National Medical Association convention and scientific assembly.

Prof. Peter Rieckmann, MD, FRCPC, FAAN, FEAN Peter Rieckmann received his medical degree from the University of Göttingen, Germany in 1988. After a postdoctoral fellowship in molecular immunology at the NIH, Bethesda, USA he completed his training in Neurology at the National Institute for Nervous Disease, London, UK and the University of Göttingen, Germany. Professor Rieckmann received German Board certification in Neurology in 1995. His academic and clinical positions have included Senior (staff) Neurologist and Professor for Neurology, Dept. of Neurology, as well as head of the Clinical Research Group for Multiple Sclerosis and Neuroimmunology, at the Julius-Mximilians University of Würzburg.
In 2007 Professor Rieckmann became the Multiple Sclerosis Society of Canada Research Chair and Director of the MS Program and Full Tenured Professor at the University of British Columbia, Vancouver, Canada. Under his leadership the Vancouver MS clinical research program was awarded Western-Pacific Research and Training Center by the MS Society of Canada. He is a founding member of the EndMS campaign in Canada and was instrumental in establishing the Center for Brain Health at UBC in Vancouver (http://www.centreforbrainhealth.ca).
His major research interests are disease modifying factors and repair mechanisms in multiple sclerosis and stroke as well as improvement of rehabilitation strategies to facilitate neuroplasticity and to promote patient engagement in acute and chronic neurological diseases. Professor Rieckmann is a Fellow of the Royal College of Physicians and Surgeons Canada (FRCPC), Fellow of the American Academy of Neurology (FAAN) and European Academy of Neurology (FEAN).

Dr. Raed Alroughani is a consultant neurologist and the director of MS clinic at Amiri and Ibn Sina hospitals. He completed his neurology residency at the University of British Columbia and subsequently obtained the neurology certification from the Royal College of Physicians & Surgeon (Canada). He then completed a fellowship in Multiple Sclerosis at the University of British Columbia. 
He is actively involved in research and he authored and co-authored more than 170 publications. Dr. Alroughani was awarded the National Prize for scientific production in the field of medical science in 2017 and the best researcher award by Amiri Hospital in 2018. 
He is a founding member and the secretary general of MENACTRIMS. He is the vice chair of the Scientific Leadership Group of MS Base Foundation.

Dr Seby John is Consultant, Vascular Neurologist and Neurointerventional Surgeon at Cleveland Clinic Abu Dhabi.
He is currently Clinical Associate Professor of Neurology at Cleveland Clinic Lerner College of Medicine, USA and Khalifa University College of Medicine, UAE.
Dr John has extensive experience in the medical and interventional management of cerebrovascular diseases.
He is an active researcher and has been an investigator in numerous international cerebrovascular clinical trials.
He has to his credit, more than 75 peer-reviewed publications and book chapters in the field of stroke and neurointerventional surgery.
He is board of directors of MENA-SINO (Middle East North Africa Stroke and interventional Neurotherapies Organization) and the UAE Vascular Neurology Chair for Mission Thrombectomy 2020+.
He is an active reviewer for multiple journals, and is on the editorial board of Clinical Neurology and Neurosurgery.

Prof. Dr. Shahrukh Hashmi is a global key opinion leader in the field of cancer, stem cells and Artificial Intelligence, Prof. Shahrukh Hashmi currently directs the Research at the Department of Health, Abu Dhabi, UAE; he practices as a professor of medicine at the Mayo Clinic (Minnesota, US) and is a professor (adjunct) of Computer Vision at MBZ-University of Artificial Intelligence (Abu Dhabi, UAE).

He chairs many international professional committees/groups including being the Chair of the Worldwide Network for Blood and Marrow Transplant’s (WBMT) Global Emergencies Committee (Geneva, Switzerland), Founding Chair of the American Society for Transplantation and Cellular Therapy Survivorship SIG (Chicago, Illinois, US), and Ex Co-Chair of the Center for International Blood & Marrow Transplant Registry’s (CIBMTR) Health Services Committee (Milwaukee, Wisconsin, US). He was Medical Director of Research at SSMC/Mayo Clinic (Abu Dhabi, UAE), and the Chairman of the Dept. of Hematology/Oncology at SSMC(Mayo) Abu Dhabi, and the Chairman of SEHA Oncology Council UAE.

He graduated from Baqai Medical University with top honors, receiving the Best Graduate Gold Medal from the President of Pakistan, and then received master’s degree (MPH) from Yale University, Connecticut, US. He is triple boarded from the US, being Diplomat of the American Board of Preventive Medicine/Public Health, Internal Medicine, and Hematology. He has served as PI or Co-PI on many industry-sponsored and NIH-sponsored trials. His research interests include premature Aging Biology, Artificial Intelligence, and Cellular therapies (CAR-T cells and Gene Therapy). He is also involved in Stem Cell Therapeutics, particularly in regenerative hematology. He has authored >350 articles in peer-reviewed journals, including in JAMA Oncology, Lancet Hematology, and NEJM, and has >12,000 citations.

His achievements include establishing the first BMT survivorship program of Mayo Clinic in Minnesota, establishing the first Clinical Trials of Saudi Arabia at King Faisal Specialist Hospital & Research Center (KFSHRC) in Riyadh, KSA, and establishing the UAE’s first Clinical Trials Unit (CTU) at SSMC/Mayo Clinic in Abu Dhabi, UAE. He also utilized anti-aging drugs for First-in-Human Trials approved as IND from the USFDA and continues to serve as PI or Co-PI on Aging trials on Healthspan and lifespan.

Heading the Research/Innovation Departments at various institutions, Prof. Hashmi is involved in healthcare business ventures, particularly with Venture Capitalists, Private Equity firms, and facilitates Limited Partnerships with respect to healthcare companies (mainly startups and series A).

As an established scientist in Cell & Gene Therapy, along with lifespan/longevity and Artificial Intelligence, Prof. Hashmi is frequently invited to international forums to deliver plenary talks and has delivered >80 invited lectures/presentations at international forums. Prof. Hashmi is also active as a Board/Advisory Board Member of many organizations including Make-A-Wish Foundation UAE, Cancer Patient Care Society (Rahma) UAE, Rose Nwatu Cancer Foundation (US/Nigeria), Emirates Thalassemia Society UAE, Make-AWish International’s Advisory Board, besides being the Associate Editor of Journal of TCT.

Dr. Shivam Om Mittal received his medical degree from Datta Meghe University of Medical Sciences University in Wardha, India. He completed his neurology residency at University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio, USA. He did postdoctoral fellowship in botulinum toxin treatment at the prestigious Yale University, where he initiated several clinical studies and streamlined unique treatment options for movement disorders. To pursue his interest further in the field of clinical movement disorders he completed a fellowship in parkinson’s disease and movement disorders at the Renowned Mayo Clinic, Minnesota, USA.<br>

Dr. Mittal lives in Abu Dhabi with his wife and two sons. He enjoys cycling, listening to music and spending time with his family.

FRCP (Edin), (MRCP)(SCE) Neurology, MRCP (UK), FCPS Neurology (Pakistan), MBBS (Pakistan)
Dr. Sidra Aurangzeb is one of the few professionals in the UK to hold dual accreditation in both 
neurology and clinical neurophysiology from the GMC. With a career that blends clinical expertise, 
leadership, and a passion for innovation, she has made significant contributions to both patient care 
and service development.
After completing seven years of intensive postgraduate training in Oxford, Dr. Aurangzeb became a 
consultant at Oxford University Hospitals, where she served as the clinical lead for telemetry services. 
She played a pivotal role in establishing the Oxford intracranial EEG service and introducing cortical 
stimulation with depth electrodes, alongside making key contributions to the development of the 
Oxford Sleep Service. Her expertise also extended to advanced neurophysiological techniques, 
including electromyography (EMG), single-fiber EMG (SFEMG), nerve conduction studies, and 
autonomic testing.
Currently a consultant at Tawam and Sheikh Tahnoon Bin Mohammad Medical City in AlAin, UAE, Dr. 
Aurangzeb is dedicated to integrating advanced neurological knowledge and cutting-edge 
neurophysiological techniques to improve patient outcomes and contribute more widely to the 
development of healthcare services in the region. She has authored numerous international papers in 
peer-reviewed journals and is passionate about teaching, mentoring the next generation of specialists

Dr. Syed Irteza Hussain, MD, is the Department Chair of Neurology in the Neurological Institute at Cleveland Clinic Abu Dhabi.

Dr. Hussain is a Consultant Neurologist with seventeen years of experience. After completing his medical degree from the prestigious Aga Khan University, he underwent extensive postgraduate training in the US. He is American Board certified in Neurology, Vascular neurology, Neurocritical Care and Neuroendovascular surgery.

Upon completion of his postgraduate training, he joined Michigan State University as an Assistant Professor in 2009, where he helped establish a 24/7 Neurointerventional Surgery Service and Fellowship Training Program. In addition to his procedures, Dr. Hussain had an integral role in the Management of Acute Stroke and critically ill neurological patients in the Hospital.

Subsequently, in 2011 he assumed the Medical Directorship of the Stroke Program at Michigan State University and its affiliate Sparrow Health system. In this administrative role, he supervised multiple successful joint commission recertifications of the Primary Stroke Center and subsequently became the first in Michigan to become a JC certified Comprehensive Stroke Center. Recognizing his services, he was promoted to Associate Professor in 2014 and awarded the Physician Leader of the Year award in 2015 by his institutions.

Dr. Hussain lives in Abu Dhabi with his wife and two daughters. He enjoys traveling with his family, listening to music and football.

Dr. Alsaadi is a Chief Medical officer and the Chair of the Neurology Department at the American Center of Psychiatry & Neurology (ACPN). He also serves as an Adjunct Professor of Neurology at Khalifa University. He was trained in Epilepsy and Clinical Neurophysiology at the University of California San Francisco and was a research fellow in Epilepsy there. He is board-certified by the American Board of Psychiatry and Neurology and by the American Board of Clinical Neurophysiology and the American Board of Neurology in Clinical Epilepsy.  

Before joining ACPN, Dr. Alsaadi was the Chief of the Neurology Department at Sheikh Khalifa Medical City for 11 years. He previously held a position as an Associate Professor of Neurology and the Director of the Adult Epilepsy Program and the Clinical Research Program at the University of California Davis. His research has focused on conducting drug study trials for new antiepileptic drugs for patients with epilepsy, quality of life in patients with epileptic and non-epileptic disorders, migraine headaches, multiple sclerosis, and neuropsychiatric comorbidities. Dr. Alsaadi has been honored with several prestigious awards for his work in the field of epilepsy. He has served on the Advisory Board of the Northern California Epilepsy Foundation and the membership committee of the American Epilepsy Society. He has previously served as the President of the Western Clinical Neurophysiology Society in the United States and as the Vice President of CEMA (Commission of the Eastern Mediterranean Affairs). He is currently the President of the Emirati League against epilepsy and the Chair of the ILAE Commission for epilepsy in the elderly. He serves as a member of the Guideline Development Group (GDG) for the WHO. He also serves on the Editorial Board for BMC Journal of Neurology and Journal of Neurosciences. He has authored and co-authored more than 85 papers and book chapters and has served as a peer-reviewer for more than 15 scientific journals. 

Dr Vishal Pawar is a Specialist Neurologist with over 13 years of experience in managing neurological and vestibular disorders. Over the last seven years, Dr Pawar has established and led a state-of-the-art Neuro-Vestibular Clinic in Dubai, treating more than 5000 vertigo patients using advanced diagnostics such as video-nystagmography, video head impulse testing, and posturography. His academic portfolio includes 38 publications, over 180 educational activities, and numerous keynote lectures internationally. He has received multiple awards for clinical and academic excellence. His expertise spans central and peripheral vestibular disorders, vestibular rehabilitation, headache medicine, and comprehensive patient-centred neurological care.

An American Board Certified Anaesthesiologist, Dr. Al Jalbout brings more than 13 years of experience in anaesthesiology, holding clinical and educational leadership roles in prestigious hospitals and institutions in the USA and her home country Lebanon. She has a special interest and is highly trained in simulation and medical education, in addition to regional and obstetric anaesthesiology. Dr. Al Jalbout received her Bachelor of Science (BS) from the American University of Beirut (AUB) in Lebanon before pursuing her Doctor of Medicine (MD) from the same university and then earning a Diploma in Simulation for Medical Education from the Lebanese American University (LAU).